Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome

NCT04009148 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT04009148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04009148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Active, not recruiting
Start date
March 1, 2019
Completion date
April 23, 2027
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca-mutated ovarian carcinoma, brip1 gene mutation, epcam, mlh1 gene mutation, msh2 a636p, msh6 gene mutation, pms2 gene mutation, rad51c gene mutation